Description
Raltegravir is an antiviral compound that inhibits HIV integrase; it is clinically used to treat HIV infection. In pre-clinical models, raltegravir decreases infection rates by preventing insertion of HIV-1 DNA into the host genome.
Product Unit Size | Cost | Quantity | Stock |
---|
Raltegravir is an antiviral compound that inhibits HIV integrase; it is clinically used to treat HIV infection. In pre-clinical models, raltegravir decreases infection rates by preventing insertion of HIV-1 DNA into the host genome.
Cas No. | 518048-05-0 |
---|---|
Purity | ≥99% |
Formula | C20H21FN6O5 |
Formula Wt. | 444.42 |
IUPAC Name | N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}-2-propanyl)-6-oxo-1,6-dihydro-4-pyrimidinecarboxamide |
Synonym | MK-0518 |
Solubility | soluble in water, slightly soluble in methanol, very slightly soluble in ethanol and acetonitrile and insoluble in isopropanol. The solubility of raltegravir increases with increasing pH such that its solubility in water is approx. 71 mg/mL. Its pKa is 6.3 |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Taramasso L, Madeddu G, Ricci E, et al. Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals. Biomed Pharmacother. 2015 Feb;69:233-6. PMID: 25661363.
Mouscadet JF, Tchertanov L. Raltegravir: molecular basis of its mechanism of action. Eur J Med Res. 2009 Nov 24;14 Suppl 3:5-16. PMID: 19959411.
Hicks C, Gulick RM. Raltegravir: the first HIV type 1 integrase inhibitor. Clin Infect Dis. 2009 Apr 1;48(7):931-9. PMID: 19231980.
TGR5 agonist.
Na+ channel blocker.
TrkB agonist.
5-HT1A partial agonist, SERT inhibitor.
Building block
Diterpene found in Taxus.
Sesquiterpene lactone found in Thapsia, used to...
Peptide, used to deliver conjugated drugs to ce...
Endogenous peptide hormone fragment, involved i...
Flavanone glycoside found in citrus fruit; SERM...
Purine derivative; CDK inhibitor.
Mycotoxin produced by Fusarium; sphingosine acy...
V2 antagonist.
Xanthine derivative; adenosine A2 antagonist, P...
Bumetanide impurity
Carcinoembryonic antigen epitope.
Proteasome inhibitor.
Triterpenoid
Semi-synthetic vinca alkaloid from Catharanthus...
KRAS inhibitor